Results 201 to 210 of about 179,738 (255)

A Case of Advanced Urothelial Carcinoma Requiring Treatment Following a Positive Interferon-Gamma Release Assay Prior to Avelumab Administration. [PDF]

IJU Case Rep
Odagiri Y, Hiyama Y, Ishida U, Nishiyama N, Yamamoto Y, Kitamura H.   +5 more
europepmc   +1 more source

Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye. [PDF]

Infect Dis Clin Microbiol
Ocaklı Aİ, Özyar-Kurtçu ŞA, Uzun M, Kaşıkçı-Çavdar M, Telli-Dizman G, Metan G, Akova M, Sarıbaş Z, Şener B.   +8 more
europepmc   +1 more source

Interferon-Gamma Release Assays Versus Tuberculin Skin Test for Active Tuberculosis Diagnosis: A Systematic Review and Diagnostic Meta-Analysis. [PDF]

Diagnostics (Basel)
Tobaiqi MA, Alshamrani MN, Sriram S, Mahmoud AB, Fadlalmola HA, Albadrani M.   +5 more
europepmc   +1 more source

Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors. [PDF]

Mol Cancer
Wawrzyniak P, Hartman ML.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interferon-Gamma

1998
During the past year, the most striking progress in our understanding of interferon-gamma has been made in the elucidation of the three-dimensional structure of the molecule and in the analysis of the molecular structure and the functional domains of the interferon-gamma receptor.
E, De Maeyer, J, De Maeyer-Guignard
openaire   +2 more sources

Interferon-Gamma Release Assays

Clinics in Laboratory Medicine, 2014
Diagnosis of latent tuberculosis infection (LTBI) should be targeted toward individuals and groups with high risk of progression to active tuberculosis (TB). Low-risk populations should not be screened. Interferon-gamma release assays (IGRAs) perform as well or better than the tuberculin skin test in most targeted populations.
Robert, Belknap, Charles L, Daley
openaire   +2 more sources